LIP
TDOC icon

Liontrust Investment Partners’s Teladoc Health TDOC Stock Holding History

Liontrust Investment Partners’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-36,000
Closed -$1.2M – 264
2022
Q2 		$1.2M Hold
36,000
– – 0.02% 212
2022
Q1 		$2.6M Hold
36,000
– – 0.03% 153
2021
Q4 		$3.31M Buy
36,000
+3,000
+9% +$359K 0.04% 151
2021
Q3 		$4.18M Buy
+33,000
New +$4.8M 0.06% 136
2020
Q4 		$1.36M Buy
+6,800
New +$1.38M 0.03% 159

Other funds holding TDOC

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
KA
Kinnevik AB Stockholm, Sweden $65.6M AUM 25.95% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Liontrust Investment Partners's TDOC Position: Q3 2022 in Review

Liontrust Investment Partners sold out of Teladoc Health (TDOC) in Q3 2022, closing a stake of 36,000 shares — an estimated $1.2M sold.

Liontrust Investment Partners first reported a position in TDOC in Q4 2020 and held it in 5 quarters. The position peaked at $4.18M in Q3 2021. 482 funds tracked by Wall St. Rank hold TDOC as of Q3 2022.

  • Liontrust Investment Partners reported no remaining Teladoc Health position as of Q3 2022 after selling out during the quarter.
  • Liontrust Investment Partners sold 36,000 Teladoc Health shares in Q3 2022, an estimated $1.2M.
  • Liontrust Investment Partners first reported a position in Teladoc Health in Q4 2020 and held it in 5 quarters.
  • Liontrust Investment Partners's Teladoc Health position peaked at $4.18M in Q3 2021.
  • 482 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2022.

Based on Liontrust Investment Partners's 13F filing for Q3 2022, filed 14 Nov 2022.